An outpatient follow-up visit with the primary care provider, endocrinologist, or diabetes educator within 1 month of discharge is advised for all patients having hyperglycemia in the hospital, with clear communication of the diabetes care plan to include medication and diabetes supply (e.g., strips, lancets) reconciliation
Patients with moderate kidney disease (eGFR 30-60) may use GLP-1 medications with careful monitoring, but severe kidney disease (eGFR below 30) makes compounded semaglutide inappropriate
Despite increasing evidence of their diverse physiological roles, the biochemical origins and signaling dynamics of these molecules remain incompletely resolved
As pharmacists and healthcare professionals, understanding the history behind life-saving medicines helps us appreciate the impact of medical innovation on patient care
Your risk of getting low blood sugar may be higher if you use Trulicity with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin